Please login to the form below

Not currently logged in
Email:
Password:

Teva board elects Yitzhak Peterburg as chairman

He succeeds Phillip Frost
Yitzhak Peterburg

The Teva board has elected Yitzhak Peterburg as its chairman, succeeding Phillip Frost who is due to step down at the end of the year.

Peterburg has worked at Teva since 2009 and has been group VP head of global branded products for the firm since 2010.

His career also includes spells as CEO and president at telecoms company Cellcom Israel and CEO at Clalit Health Services, Israel's leading healthcare provider.

Frost, who was appointed chairman since, March 2010, has overseen an era of change for Teva as it looks to move beyond its generics background and build its specialty pharmaceuticals business.

Frost was said to have a strained relationship with Teva's former CEO Jeremy Levin who left the company in 2013 to be replaced by Erez Vigodman at the beginning of 2014.

Teva also appointed Sol Barer, the former chief executive of Celgene, as a director.

28th November 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics